Inflazyme Pharmaceuticals
Officials at Inflazyme Pharmaceuticals discuss recent developments
Published in Healthcare Mergers, Acquisitions and Ventures Week, May 5th, 2007
This trend article is an immediate alert from NewsRx to identify the most recent news developments at Inflazyme Pharmaceuticals.
Report 1: Inflazyme Pharmaceuticals, Ltd., (IZP) announced that it has successfully completed its previously announced nonbrokered unit offering with the issue of 17.6 million units at $0.17 per unit for gross proceeds of CDN$3 million.
Each unit comprises 1 common share of Inflazyme stock and one-half of 1 share purchase warrant. Each whole warrant has a 12-month term from the date of closing and an exercise price of $0.29 per...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Mergers, Acquisitions and Ventures Week
More Articles from Healthcare Mergers, Acquisitions and Ventures Week
- 3D Systems Corporation
3D Systems Announces New Hearing Aid Manufacturing System - Access Pharmaceuticals, Inc.
Access Pharmaceuticals Signs Definitive Merger Agreement With Somanta Pharmaceuticals - ACS, Inc.
ACS EDI Gateway Receives Electronic Healthcare Accreditation From Independent Agency - AcuNetx, Inc.
AcuNetx Buys Back Nearly One Percent of Its Outstanding Shares - Acusis
Acusis Acquires Digital Records Corporation Adding Capabilities for Significant Growth - Adaltis
Adaltis Receives Important Commitment for EclecticaTM Instruments in Mexico - More from this issue of Healthcare Mergers, Acquisitions and Ventures Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
